|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
1 months to Dec 31, 2017
|
FY2016
10 months to Dec 31, 2016
|
|
|---|---|---|---|---|
| Revenues: | ||||
| Premiums | ||||
| Net investment income | ||||
| Net investment gains (losses) | ||||
| Insurance and investment product fees and other | ||||
| Total revenues | ||||
| Benefits and expenses: | ||||
| Benefits and other changes in policy reserves | ||||
| Acquisition and operating expenses, net of deferrals | ||||
| Amortization of intangibles | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Interest expense | ||||
| Income (loss) before income taxes | ||||
| Predecessor | ||||
| Total income (loss) before income taxes | ||||
| Income tax (expense) benefit | ||||
| Predecessor | ||||
| Total income tax (expense) benefit | ||||
| Net income (loss) | ||||
| Less Preferred stock dividend | ||||
| Net income (loss) available to common shareholders | ||||
| Net income (loss) per common share | ||||
| Basic (in USD per share) | ||||
| Diluted (in USD per share) | ||||
| Weighted average common shares used in computing net income (loss) per common share: | ||||
| Basic (in shares) | ||||
| Diluted (in shares) | ||||
| Other-than-temporary impairments | ||||
| Portion of other-than-temporary impairments included in other comprehensive income | ||||
| Gains (losses) on derivatives and embedded derivatives | ||||
| Other investment gains | ||||
| Other investment gains (losses) | ||||
Loading...